Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NVO

Novo Nordisk ADR

Oct 30 • 04:00PM ET

50.04

-1.33 -2.59 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: PPH AVDE PVAL PID WCMI APIE RVER DFIC DIVZ OZEM

Scroll to Statements

Index	-	P/E	13.79	EPS (ttm)	3.63	Insider Own	0.01%	Shs Outstand	3.37B	Perf Week	-5.99%
Market Cap	168.44B	Forward P/E	12.59	EPS next Y	3.97	Insider Trans	0.00%	Shs Float	3.37B	Perf Month	-15.43%
Enterprise Value	181.08B	PEG	1.34	EPS next Q	0.77	Inst Own	9.17%	Short Float	0.79%	Perf Quarter	3.84%
Income	16.18B	P/S	3.71	EPS this Y	16.85%	Inst Trans	-1.50%	Short Ratio	1.60	Perf Half Y	-23.72%
Sales	45.45B	P/B	8.40	EPS next Y	7.55%	ROA	25.10%	Short Interest	26.67M	Perf YTD	-41.83%
Book/sh	5.95	P/C	56.54	EPS next 5Y	10.29%	ROE	75.95%	52W High	113.76 -56.01%	Perf Year	-55.46%
Cash/sh	0.88	P/FCF	17.75	EPS past 3/5Y	25.78% 21.74%	ROIC	40.28%	52W Low	45.05 11.08%	Perf 3Y	-7.48%
Dividend Est.	1.81 (3.61%)	EV/EBITDA	7.74	Sales past 3/5Y	23.46% 18.15%	Gross Margin	83.94%	Volatility	2.07% 1.99%	Perf 5Y	41.48%
Dividend TTM	1.73 (3.45%)	EV/Sales	3.98	EPS Y/Y TTM	24.50%	Oper. Margin	46.36%	ATR (14)	1.52	Perf 10Y	86.54%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	0.56	Sales Y/Y TTM	21.52%	Profit Margin	35.60%	RSI (14)	27.76	Recom	1.91
Dividend Gr. 3/5Y	28.20% 21.81%	Current Ratio	0.78	EPS Q/Q	39.83%	SMA20	-9.94%	Beta	0.64	Target Price	69.20
Payout	35.93%	Debt/Eq	0.59	Sales Q/Q	18.96%	SMA50	-11.11%	Rel Volume	1.26	Prev Close	51.37
Employees	76302	LT Debt/Eq	0.52	Earnings	Nov 05 BMO	SMA200	-25.68%	Avg Volume	16.65M	Price	50.04
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.02% 0.43%	Trades		Volume	20,922,559	Change	-2.59%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120

Show Previous Ratings

Today 04:09PM	Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera (Investor's Business Daily)
02:27PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
02:16PM	Pfizer said to mull suing Novo Nordisk over Metsera bid (Investing.com)
02:11PM	Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. (Barrons.com)
01:11PM	Chipotle drags fast casual stocks lower, Meta reports raising $125B (Yahoo Finance Video)
12:57PM	Loading…
12:57PM	Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales (Zacks)
12:39PM	Novo Crashes Pfizer's Party with Surprise $6.5B Power Move for Metsera (GuruFocus.com)
09:25AM	Novo Nordisk's bid for Metsera, Eli Lilly boosts revenue outlook (Yahoo Finance Video)
09:13AM	Novo Nodrisk stock dips on aggressive odder to buy Metsera, reckless says Pfizer (Investing.com)
09:08AM	Novo Nordisk A/S (NVO)'s Top Investor Decides to Take Control of its Board, Reports Reuters (Insider Monkey)
08:09AM	Eli Lilly's stock jumps as Zepbound sales nearly triple at lower prices (MarketWatch)
07:11AM	Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker. (Barrons.com)
06:57AM	Pfizer Addresses Proposal for Metsera (Business Wire)
Oct-29-25 08:22AM	What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree? (Zacks)
06:20AM	1 Incredible Reason to Buy Novo Nordisk Stock (NVO) in November -- or Sooner (Motley Fool)
05:45AM	Loading…
05:45AM	Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried? (Motley Fool)
Oct-28-25 05:45PM	Novo Nordisk (NVO) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
09:53AM	If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These (Motley Fool)
Oct-27-25 12:21PM	What Is 1 of the Best Pharmaceutical Stocks to Buy Now? (Motley Fool)
09:52AM	Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings (Zacks)
09:00AM	Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know (Zacks)
Oct-26-25 06:05AM	Is Omeros Corporation (OMER) One of the Hot Stocks to Buy with Huge Upside Potential? (Insider Monkey)
Oct-24-25 11:39AM	NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now? (Zacks)
Oct-23-25 10:39AM	Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks)
09:55AM	How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q3 Results? (Zacks)
08:16AM	Breakout Momentum Plays You Need to Know About (MarketBeat)
07:40AM	Is Novo Nordisk (NVO) The Best Weight-Loss Stock to Buy? (Insider Monkey)
05:02AM	Strength Seen in Innoviva (INVA): Can Its 5.5% Jump Turn into More Strength? (Zacks)
Oct-22-25 10:35PM	J.P. Morgan Maintains a Buy on Novo Nordisk (NVO) (Insider Monkey)
05:59PM	Novo Nordisk A/S (NVO): A Bull Case Theory (Insider Monkey)
05:45PM	Loading…
05:45PM	Novo Nordisk (NVO) Declines More Than Market: Some Information for Investors (Zacks)
12:48PM	Market Meltdown Coming? These 2 ETFs Are Ready to Surge If Stocks Tank (24/7 Wall St.)
11:04AM	NVO Stock Falls Amid Governance Shift as Foundation Seeks New Board (Zacks)
07:41AM	Omeros Sells Exclusive Global Rights for Drug Zaltenibart to Novo Nordisk (Insider Monkey)
04:35AM	Novo Nordisk Power Struggle Erupts: Foundation Forces Leadership Overhaul After CEO Clash (GuruFocus.com)
04:24AM	Novo Nordisk Chair and Board Members Step Down After Rift With Controlling Foundation (GuruFocus.com)
12:00AM	US pharma price probe raises threat of new drug tariffs (Financial Times)
Oct-21-25 01:19PM	HSBC's Rajesh Kumar on Novo Nordisk: We want to see management team execute turnaround strategy (CNBC TV)
09:30AM	NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients (Zacks)
09:18AM	Novo Nordisk in active talks with Trump administration on MFN (CNBC TV)
08:54AM	The Ozempic maker shakes up its board. It has been a year of turmoil for Novo Nordisk. (MarketWatch)
05:05AM	These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall (Motley Fool)
05:00AM	Did Eli Lilly Just Say "Checkmate" to Novo Nordisk? (Motley Fool)
Oct-20-25 03:45PM	Novo Nordisk Wins FDA OK for Oral Heart Drug (GuruFocus.com)
09:07AM	2 Beaten-Down Stocks to Buy and Hold for the Next Decade (Motley Fool)
04:20AM	These 3 Obesity Drug Stocks Are Set to Soar This Fall and Beyond (Motley Fool)
Oct-17-25 08:06PM	President Trump targets $150 MFN price for GLP-1s (CNBC TV)
04:39PM	Stock Market Today: Stocks Higher In Strong Week On Trump News; Oracle Dives (Live Coverage) (Investor's Business Daily)
04:38PM	Stock Market Today: Indexes Up In Strong Week On Trump News; Oracle Dives (Live Coverage) (Investor's Business Daily)
04:23PM	Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive. (Investor's Business Daily)
02:02PM	Stock Market Today: Dow Up As Financial Stocks Rise, Trump Tempers China Tariff View (Live Coverage) (Investor's Business Daily)
12:33PM	Stock Market Today: Dow Higher As Moody's Chief Allays Bank Fears; Gold Stocks Dive (Live Coverage) (Investor's Business Daily)
11:44AM	NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs (Zacks)
10:58AM	Pharma Stocks Fall After Trump Says Ozempic Could Be Much Cheaper (The Wall Street Journal)
10:39AM	Novo, Lilly Fall as Trump Touts Much Lower Ozempic Price (Bloomberg)
10:16AM	Eli Lilly, Novo Nordisk Stocks Drop. Trump Targets Ozempic, Fat Loss Drug Prices. (Barrons.com)
10:01AM	Trump says Ozempic will get much cheaper. Novo Nordisk and Eli Lilly shares tumble (Quartz)
09:43AM	Stock Market Today: Dow Up Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
09:36AM	Drugmakers slide on Trump comments, EssilorLuxottica's Meta glasses (Yahoo Finance Video)
09:35AM	Novo Nordisk Shares Fall After Trump Pledges Weight-Loss Drug Price Cuts (GuruFocus.com)
09:30AM	Pre-Q3 Earnings: Is Viking Therapeutics Stock a Portfolio Must-Have? (Zacks)
08:48AM	Stock Market Today: Dow Edges Up Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
08:12AM	Stock Market Today: Dow Falls Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
07:35AM	Novo Nordisk falls on Trump threat to lower Ozempic prices and other morning movers (MarketWatch)
07:18AM	Eli Lilly, Novo Nordisk Stocks Drop After Trump's Ozempic Price Comment. What to Know. (Barrons.com)
06:22AM	The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics (Zacks)
Oct-16-25 05:45PM	Novo Nordisk (NVO) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
05:22PM	Novo Nordisk, Eli Lilly slide after Trump comments on weight loss drug pricing (Investing.com)
01:55PM	LLY's Oral GLP-1 Pill Scores Another Pair of Diabetes Wins (Zacks)
11:10AM	NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease Portfolio (Zacks)
09:31AM	How Will Mounjaro and Zepbound Sales Aid Lilly's Upcoming Q3 Results? (Zacks)
03:39AM	A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now? (Motley Fool)
Oct-15-25 04:15PM	Novo Nordisk's Akero Therapeutics Buy Targets Eli Lilly's Lead (MarketBeat)
04:12PM	Omeros Catapults 154% On A Surprise $2.1 Billion Deal With Novo Nordisk (Investor's Business Daily)
03:26PM	Novo Nordisk Makes $2.1 Billion Rare-Disease Bet After Losing Ground in Obesity Race (GuruFocus.com)
12:49PM	Omeros Catapults Almost 150% On A Surprise $2.1 Billion Deal With Novo Nordisk (Investor's Business Daily)
08:40AM	Pharma M&A Activity Picks Up Pace: What Does It Signal for 2026? (Zacks)
04:00AM	Meet the 1.4% Yield Dividend Stock That Could Soar in 2026 (Motley Fool)
Oct-14-25 09:00AM	Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Oct-13-25 07:23AM	The Smartest Growth Stock to Buy With $100 Right Now (Motley Fool)
06:10AM	Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? (Motley Fool)
05:21AM	3 Top Healthcare Stocks to Buy in October (Motley Fool)
Oct-12-25 09:43AM	Should You Buy Novo Nordisk Right Now? (Motley Fool)
Oct-10-25 02:52PM	Bill Gates, PAHO Aim To Expand Global Access To Weight-Loss Drugs (GuruFocus.com)
02:43PM	Novo Nordisk to Close Cell Therapy Division Amid Global Restructuring (GuruFocus.com)
09:54AM	Can Novo Nordisk's Aggressive Deal-Making Offset Semaglutide Reliance? (Zacks)
06:35AM	Earnings, Fed Rates Mean Stocks Can Ignore the Shutdown. This Could Change That. (Barrons.com)
04:05AM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
Oct-09-25 05:45PM	Novo Nordisk (NVO) Dips More Than Broader Market: What You Should Know (Zacks)
04:04PM	Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $5.2 Billion Buyout (Investor's Business Daily)
11:17AM	Novo Nordisk Is Buying Akero Therapeutics. Its More Good News for Biotech Stocks. (Barrons.com)
11:00AM	Is Novo Nordisk Stock a Sell Despite its 10% Price Rally in a Month? (Zacks)
10:11AM	Akero Therapeutics Stock Surges on Novo Nordisk Buyout (Schaeffer's Research)
07:31AM	Akero Therapeutics Stock Soars. Novo Nordisk Is Buying the Biotech for up to $5.2 Billion. (Barrons.com)
06:59AM	Novo Nordisk is paying up to $5.2 billion for a San Francisco biotech working on liver disease (MarketWatch)
Oct-08-25 01:02PM	Hims Stock, Up 138%: IBD Stock Of The Day Makes Another Breakout Run (Investor's Business Daily)
Oct-07-25 02:58PM	Novo Nordisk Cuts Jobs At Key U.S. Drug Plant (GuruFocus.com)
02:57PM	Novo Nordisk Cuts U.S. Production Jobs Amid Global Restructuring (GuruFocus.com)
11:32AM	SKYE Stock Plunges 60% as Obesity Candidate Misses Key Phase II Goal (Zacks)
09:33AM	Where Will LLY Be in 5 Years? (Motley Fool)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience